HELX icon

Franklin Genomic Advancements ETF

10 hedge funds and large institutions have $3.11M invested in Franklin Genomic Advancements ETF in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
GT
1
Glenview Trust
Kentucky
$1.07M 32,625 -9,610 -23%
Jane Street
2
Jane Street
New York
$455K 13,886 -11,923 -46%
GS
3
GTS Securities
New York
$449K 13,704 -35,228 -72%
Citadel Advisors
4
Citadel Advisors
Florida
$363K 11,072 +11,072 New
LPL Financial
5
LPL Financial
California
$303K 9,238 +2,175 +31%
Commonwealth Equity Services
6
Commonwealth Equity Services
Massachusetts
$231K 7,042
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$227K 6,934 -582 -8%
Osaic Holdings
8
Osaic Holdings
Arizona
$9.73K 297 -100 -25%
HI
9
Harbour Investments
Wisconsin
$6.16K 188
Citigroup
10
Citigroup
New York
$491 15 +15 New
UBS Group
11
UBS Group
Switzerland
-1,628 Closed
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
CFGS
13
Concourse Financial Group Securities
Alabama